Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NEMO/IKK gamma: linking NF-kappa B to human disease.

× No keyword cloud information.

20 in total

Review 1. EDA signaling and skin appendage development.

Authors: Chang-Yi Cui; David Schlessinger
Journal: Cell Cycle Date: 2006-09-14 Impact factor: 4.534

2. Decreased expression in nuclear factor-κB essential modulator due to a novel splice-site mutation causes X-linked ectodermal dysplasia with immunodeficiency.

Authors: Shuhei Karakawa; Satoshi Okada; Miyuki Tsumura; Yoko Mizoguchi; Norioki Ohno; Shin'ichiro Yasunaga; Motoaki Ohtsubo; Tomoki Kawai; Ryuta Nishikomori; Takemasa Sakaguchi; Yoshihiro Takihara; Masao Kobayashi
Journal: J Clin Immunol Date: 2011-07-01 Impact factor: 8.317

3. Quantitation of the dynamic profiles of the innate immune response using multiplex selected reaction monitoring-mass spectrometry.

Authors: Yingxin Zhao; Bing Tian; Chukwudi B Edeh; Allan R Brasier
Journal: Mol Cell Proteomics Date: 2013-02-15 Impact factor: 5.911

4. Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation.

Authors: Sebastian Tegethoff; Joachim Behlke; Claus Scheidereit
Journal: Mol Cell Biol Date: 2003-03 Impact factor: 4.272

5. Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis.

Authors: Isra Darwech; Jesse Otero; Muhammad Alhawagri; Simon Dai; Yousef Abu-Amer
Journal: J Cell Biochem Date: 2009-12-15 Impact factor: 4.429

6. NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain.

Authors: E Laplantine; E Fontan; J Chiaravalli; T Lopez; G Lakisic; M Véron; F Agou; Alain Israël
Journal: EMBO J Date: 2009-09-17 Impact factor: 11.598

Review 7. Inflammation, cancer, and bone loss.

Authors: Yousef Abu-Amer
Journal: Curr Opin Pharmacol Date: 2009-07-02 Impact factor: 5.547

Review 8. Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.

Authors: Karine Breckpot; David Escors
Journal: Endocr Metab Immune Disord Drug Targets Date: 2009-12 Impact factor: 2.895

Review 9. NF-κB signaling and bone resorption.

Authors: Y Abu-Amer
Journal: Osteoporos Int Date: 2013-03-07 Impact factor: 4.507

10. Expression of an IKKgamma splice variant determines IRF3 and canonical NF-kappaB pathway utilization in ssRNA virus infection.

Authors: Ping Liu; Muping Lu; Bing Tian; Kui Li; Roberto P Garofalo; Deborah Prusak; Thomas G Wood; Allan R Brasier
Journal: PLoS One Date: 2009-11-26 Impact factor: 3.240